12885_2018_4887_MOESM1_ESM.docx (43.76 kB)
Additional file 1: of Receptor activator of nuclear factor kB ligand, osteoprotegerin, and risk of death following a breast cancer diagnosis: results from the EPIC cohort
journal contribution
posted on 2018-10-22, 05:00 authored by Danja Sarink, Helena Schock, Theron Johnson, Jenny Chang-Claude, Kim Overvad, Anja Olsen, Anne Tjønneland, Patrick Arveux, Agnès Fournier, Marina Kvaskoff, Heiner Boeing, Anna Karakatsani, Antonia Trichopoulou, Carlo La Vecchia, Giovanna Masala, Claudia Agnoli, Salvatore Panico, Rosario Tumino, Carlotta Sacerdote, Carla van Gils, Petra Peeters, Elisabete Weiderpass, Antonio Agudo, Miguel Rodríguez-Barranco, José Huerta, Eva Ardanaz, Leire Gil, Kay Kaw, Julie Schmidt, Laure Dossus, Mathilde His, Dagfinn Aune, Elio Riboli, Rudolf Kaaks, Renée FortnerTable S1. Circulating concentrations of OPG and risk of death following a breast cancer diagnosis, by ER subtype and stratified by BMI at blood collection. Table S2 The sRANKL/OPG ratio and risk of death following a breast cancer diagnosis, by ER subtype. Table S3 sRANKL/OPG cross-classification and risk of death following a breast cancer diagnosis, by ER subtype. (DOCX 43 kb)
